| PCS-2023 > 3 > 3E > 3E0 > 3E0F |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0F | Introduction, Respiratory Tract | |
3E0F3 | Percutaneous | |
3E0F30 | Antineoplastic | |
3E0F304 | Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Percutaneous Approach | |
3E0F305 | Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach | |
3E0F30M | Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach | |
3E0F32 | Anti-infective | |
3E0F328 | Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach | |
3E0F329 | Introduction of Other Anti-infective into Respiratory Tract, Percutaneous Approach | |
3E0F33 | Anti-inflammatory | |
3E0F33Z | Introduction of Anti-inflammatory into Respiratory Tract, Percutaneous Approach | |
3E0F36 | Nutritional Substance | |
3E0F36Z | Introduction of Nutritional Substance into Respiratory Tract, Percutaneous Approach | |
3E0F37 | Electrolytic and Water Balance Substance | |
3E0F37Z | Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Percutaneous Approach | |
3E0F3B | Anesthetic Agent | |
3E0F3BZ | Introduction of Anesthetic Agent into Respiratory Tract, Percutaneous Approach | |
3E0F3H | Radioactive Substance | |
3E0F3HZ | Introduction of Radioactive Substance into Respiratory Tract, Percutaneous Approach | |
3E0F3K | Other Diagnostic Substance | |
3E0F3KZ | Introduction of Other Diagnostic Substance into Respiratory Tract, Percutaneous Approach | |
3E0F3N | Analgesics, Hypnotics, Sedatives | |
3E0F3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Percutaneous Approach | |
3E0F3T | Destructive Agent | |
3E0F3TZ | Introduction of Destructive Agent into Respiratory Tract, Percutaneous Approach | |
3E0F3G | Other Therapeutic Substance | |
3E0F3GC | Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Approach | |
3E0F3S | Gas | |
3E0F3SD | Introduction of Nitric Oxide Gas into Respiratory Tract, Percutaneous Approach | |
3E0F3SF | Introduction of Other Gas into Respiratory Tract, Percutaneous Approach | |
3E0F7 | Via Natural or Artificial Opening | |
3E0F70 | Antineoplastic | |
3E0F704 | Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F705 | Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F70M | Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F72 | Anti-infective | |
3E0F728 | Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F729 | Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F73 | Anti-inflammatory | |
3E0F73Z | Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F76 | Nutritional Substance | |
3E0F76Z | Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F77 | Electrolytic and Water Balance Substance | |
3E0F77Z | Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F7B | Anesthetic Agent | |
3E0F7BZ | Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F7H | Radioactive Substance | |
3E0F7HZ | Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F7K | Other Diagnostic Substance | |
3E0F7KZ | Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F7N | Analgesics, Hypnotics, Sedatives | |
3E0F7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F7T | Destructive Agent | |
3E0F7TZ | Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F7G | Other Therapeutic Substance | |
3E0F7GC | Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F7S | Gas | |
3E0F7SD | Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F7SF | Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening | |
3E0F8 | Via Natural or Artificial Opening Endoscopic | |
3E0F80 | Antineoplastic | |
3E0F804 | Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F805 | Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F80M | Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F82 | Anti-infective | |
3E0F828 | Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F829 | Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F83 | Anti-inflammatory | |
3E0F83Z | Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F86 | Nutritional Substance | |
3E0F86Z | Introduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F87 | Electrolytic and Water Balance Substance | |
3E0F87Z | Introduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F8B | Anesthetic Agent | |
3E0F8BZ | Introduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F8H | Radioactive Substance | |
3E0F8HZ | Introduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F8K | Other Diagnostic Substance | |
3E0F8KZ | Introduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F8N | Analgesics, Hypnotics, Sedatives | |
3E0F8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F8T | Destructive Agent | |
3E0F8TZ | Introduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F8G | Other Therapeutic Substance | |
3E0F8GC | Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F8S | Gas | |
3E0F8SD | Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F8SF | Introduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic | |
3E0F4 | Percutaneous Endoscopic | |
3E0F4G | Other Therapeutic Substance | |
3E0F4GC | Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Endoscopic Approach | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |